About Us

VISION

King Pharmaceuticals strives to be a recognized leader and partner of choice in bringing innovative, clinically-differentiated pharmaceutical therapies and technologies to market.

WHO WE ARE

King, an S&P 500 Index company, is a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in specialty-driven markets including neuroscience, hospital and acute care medicines. read more »

WHY CHOOSE KING?

King’s business model offers the best of a big and small company in one fully integrated pharmaceutical company. King is an agile corporation whose size enables it to build close, personal one-on-one relationships with business development partners and move quickly to capitalize on scientific advances that address patient needs. read more »

STRATEGY

King Pharmaceuticals is achieving its vision through an enterprise-wide focus on specialty-driven markets , organic growth and a disciplined business development process.

To see how King is executing on its strategy,click here.

For Fast Facts about King,click here.